ArticleCureus2026
The Importance of Echocardiographic Persistence in Predicting Apical Aneurysms via Color Doppler in Hypertrophic Cardiomyopathy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting sudden cardiac death in hypertrophic cardiomyopathy: the indispensable role of echocardiographic persistence before advanced algorithms.The international journal of cardiovascular imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In clinical practice, apical hypertrophic cardiomyopathy (HCM) is an insidious phenotype that often conceals significant structural complications. Our case demonstrates a critical "clinical pearl": the necessity of echocardiographic persistence. While standard apical four-chamber views failed to reveal a large apical aneurysm, our clinical suspicion - triggered solely by a high-velocity apical color Doppler jet - led to meticulous probe manipulations (intercostal "sliding" and "tilt") that eventually unmasked a characteristic "hourglass" aneurysmal sac. Beyond the diagnostic challenge, this case highlights a significant discrepancy between current guidelines regarding risk stratification. Despite the presence of a large aneurysm, our patient's sudden cardiac death (SCD) risk was calculated as only 0.68% (low risk) according to the ESC 2014 risk score. However, the 2020 AHA/ACC guidelines correctly categorize this patient as high-risk (class IIa indication for an implantable cardioverter-defibrillator) based on the presence of an apical aneurysm alone. Our report provides concrete evidence of how morphological-only calculators can remain "blind" to life-threatening risks in this specific patient subset. We believe that this case will be of great interest to the readership, emphasizing both the technical nuances of echocardiographic assessment and the vital importance of guideline-directed risk management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.